Key facts
- It has raised $160K; the latest was Later Stage VC in Apr 2026.
- Notable investors include gener8tor, Expert DOJO, Global Insurance Accelerator.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Clever RX
- ·The full record, as it builds
Funding rounds
No funding rounds for Clever RX are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Clever RX
Developer of a pharmacy savings application designed to drive down prescription drug costs. The company's application helps to find the low price of drugs, and provides notifications for potential drug interactions, independent drug reviews, and alternative drug recommendations, enabling consumers to save on health and wellness products they already buy.
- Sector
- Healthcare
- HQ
- Saint Charles, MO, United States
- Founded
- 2019
- Employees
- 11
- Website
- cleverrx.com/
- Ownership
- Privately Held (backing)
Clever RX doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Clever RX shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Clever RX in its N-PORT filings yet. We sweep new filings monthly.